Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies

被引：0
|
作者：
Boulos Haraoui
Gustavo Casado
László Czirják
Andrew Taylor
Lingli Dong
Peter Button
Yves Luder
Roberto Caporali
机构：
[1] Institut de Rhumatologie de Montréal,Department of Rheumatology
[2] Hospital Militar Central,Rheumatology and Immunology Clinic, Medical Center
[3] University of Pécs,Medicine and Pharmacology RPH Unit, Royal Perth Hospital
[4] University of Western Australia,Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College
[5] Huazhong University of Science and Technology,Department of Rheumatology
[6] OzBiostat Pty Ltd,undefined
[7] F. Hoffmann-La Roche,undefined
[8] Ltd,undefined
[9] University of Pavia,undefined
[10] IRCCS S. Matteo Foundation,undefined
来源：
Rheumatology and Therapy | 2019年 / 6卷
关键词：
ACT-UP; Biologic factors; Rheumatoid arthritis; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：231 / 243
页数：12
相关论文
共 38 条
  • [31] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Alan Kivitz
    Alvin F. Wells
    Juan I. Vargas
    Herbert S. B. Baraf
    Maureen Rischmueller
    Justin Klaff
    Nasser Khan
    Yihan Li
    Kyle Carter
    Alan Friedman
    Patrick Durez
    Rheumatology and Therapy, 2023, 10 : 901 - 915
  • [32] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Kivitz, Alan
    Wells, Alvin F. F.
    Vargas, Juan I. I.
    Baraf, Herbert S. B.
    Rischmueller, Maureen
    Klaff, Justin
    Khan, Nasser
    Li, Yihan
    Carter, Kyle
    Friedman, Alan
    Durez, Patrick
    RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 901 - 915
  • [33] Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study
    Bessette, Louis
    Haraoui, Boulos
    Chow, Andrew
    Fortin, Isabelle
    Dixit, Sanjay
    Khraishi, Majed
    Haaland, Derek
    Elmoufti, Sami
    Staelens, Fabienne
    Bogatyreva, Irina
    Syrotuik, Jerry
    Shaikh, Saeed
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2019, 11 : 1 - 14
  • [34] Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
    Ryoko Sakai
    Soo-Kyung Cho
    Toshihiro Nanki
    Kaori Watanabe
    Hayato Yamazaki
    Michi Tanaka
    Ryuji Koike
    Yoshiya Tanaka
    Kazuyoshi Saito
    Shintaro Hirata
    Koichi Amano
    Hayato Nagasawa
    Takayuki Sumida
    Taichi Hayashi
    Takahiko Sugihara
    Hiroaki Dobashi
    Shinsuke Yasuda
    Tetsuji Sawada
    Kazuhiko Ezawa
    Atsuhisa Ueda
    Takao Fujii
    Kiyoshi Migita
    Nobuyuki Miyasaka
    Masayoshi Harigai
    Arthritis Research & Therapy, 17
  • [35] Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus
    Ishida K.
    Shiraki K.
    Yoshiyasu T.
    Drugs in R&D, 2015, 15 (4) : 307 - 317
  • [36] Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy
    Tasso, M.
    Bertolini, N.
    Mostacciuolo, E.
    Passavanti, S.
    Luppino, J. M. E.
    Del Puente, A.
    Peluso, R.
    Santelli, F.
    Scarpa, R.
    Costa, L.
    Caso, F.
    REUMATISMO, 2022, 74 (03) : 131 - 136
  • [37] Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan
    Tsutomu Takeuchi
    Yoshiya Tanaka
    Sakae Tanaka
    Atsushi Kawakami
    Yeong-Wook Song
    Yi-Hsing Chen
    Mitsuhiro Rokuda
    Hiroyuki Izutsu
    Satoshi Ushijima
    Yuichiro Kaneko
    Rheumatology and Therapy, 2021, 8 : 425 - 442
  • [38] Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Tanaka, Sakae
    Kawakami, Atsushi
    Song, Yeong-Wook
    Chen, Yi-Hsing
    Rokuda, Mitsuhiro
    Izutsu, Hiroyuki
    Ushijima, Satoshi
    Kaneko, Yuichiro
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 425 - 442
1234